368 related articles for article (PubMed ID: 16538801)
21. Accessibility to new drugs for use in military and civilian exigencies when traditional human efficacy studies are not feasible; determination under the interim rule that informed consent is not feasible for military exigencies; request for comments--FDA. Request for comments.
Fed Regist; 1997 Jul; 62(147):40996-1001. PubMed ID: 10169831
[TBL] [Abstract][Full Text] [Related]
22. [Ethical or legal problems in Operation Desert Storm?].
Wilczek H
Cas Lek Cesk; 1994 May; 133(10):315-6. PubMed ID: 8004657
[No Abstract] [Full Text] [Related]
23. Bioterrorism, biodefense, and biotechnology in the military: a comparative analysis of legal and ethical issues in the research, development, and use of biotechnological products on American and British soldiers.
Melson AR
Albany Law J Sci Technol; 2004; 14(2):E1-E44. PubMed ID: 16521317
[No Abstract] [Full Text] [Related]
24. Should combat troops be given the option of refusing investigational drug treatment?
Ryan RP
Food Drug Law J; 1997; 52(4):377-400. PubMed ID: 10346671
[No Abstract] [Full Text] [Related]
25. FDA, off-label use, and informed consent: debunking myths and misconceptions.
Beck JM; Azari ED
Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
[No Abstract] [Full Text] [Related]
26. Preparedness for bioterrorism?
Cohen HW; Sidel VW; Gould RM
N Engl J Med; 2001 Nov; 345(19):1423-4. PubMed ID: 11794178
[No Abstract] [Full Text] [Related]
27. Medicine and war.
Nightingale SL
N Engl J Med; 1992 Oct; 327(15):1097-8. PubMed ID: 1522850
[No Abstract] [Full Text] [Related]
28. Moral responsiveness in pediatric research ethics.
Moeller CJ
Am J Bioeth; 2003; 3(4):W1-W3. PubMed ID: 14744302
[No Abstract] [Full Text] [Related]
29. Drugs and vaccines for the common defense: refining FDA regulation to promote the availability of products to counter biological attacks.
Javitt GH
J Contemp Health Law Policy; 2002; 19(1):37-116. PubMed ID: 12733223
[No Abstract] [Full Text] [Related]
30. Military personnel may have been human subjects without their informed consent.
Maloney DM
Hum Res Rep; 2003 Aug; 18(8):9. PubMed ID: 15119340
[No Abstract] [Full Text] [Related]
31. Violations of informed consent during war.
Schofer JM
JAMA; 1999 May; 281(17):1657. PubMed ID: 10235163
[No Abstract] [Full Text] [Related]
32. Assent and dissent in 407 research with children.
Murphy TF
Am J Bioeth; 2003; 3(4):18-9. PubMed ID: 14744313
[No Abstract] [Full Text] [Related]
33. Blinded by bioterrorism: public health and liberty in the 21st century.
Annas GJ
Health Matrix Clevel; 2003; 13(1):33-70. PubMed ID: 14569657
[No Abstract] [Full Text] [Related]
34. Bioterrorism: a clear and present danger.
Lane HC; Montagne JL; Fauci AS
Nat Med; 2001 Dec; 7(12):1271-3. PubMed ID: 11726956
[No Abstract] [Full Text] [Related]
35. Human subjects research. Panel blasts ethics, science of 1940s Guatemala studies.
Kaiser J
Science; 2011 Sep; 333(6047):1211. PubMed ID: 21885749
[No Abstract] [Full Text] [Related]
36. Adjusting FDA policies to address bioterrorist threat.
Fox JL
Nat Biotechnol; 1999 Apr; 17(4):323-4. PubMed ID: 10207870
[No Abstract] [Full Text] [Related]
37. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
Daemmrich A; Krucken G
Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
[No Abstract] [Full Text] [Related]
38. Regulation of research on the decisionally impaired: history and gaps in the current regulatory system.
Moreno JD
J Health Care Law Policy; 1998; 1(1):1-21. PubMed ID: 15573427
[No Abstract] [Full Text] [Related]
39. Bioterrorism. Vaccines for biodefense: a system in distress.
Cohen J; Marshall E
Science; 2001 Oct; 294(5542):498-501. PubMed ID: 11641476
[No Abstract] [Full Text] [Related]
40. Unit 731 and moral repair.
Hickey D; Li SS; Morrison C; Schulz R; Thiry M; Sorensen K
J Med Ethics; 2017 Apr; 43(4):270-276. PubMed ID: 27003420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
